Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: J Clin Pharmacol. 2010 Apr 16;51(3):389–396. doi: 10.1177/0091270010365559

Table I.

Stereospecific pharmacokinetic variables in healthy subjects (N=10) for oral metoprolol IR and ER given with and without paroxetine.

Variable Metoprolol
Enantiomer
Metoprolol IR 50mg
Metoprolol ER 100mg
Without
paroxetine
With
paroxetine
Without
paroxetine
With
paroxetine
AUC0–24h S 138±98 511±116 ** 173±96 599±174 **
(ng*h/mL) R 84±75 436±141 ** 120±71a 521±183 **
Cl/F (L/h) S 194±171 47±15 * 138±90b 56±46c
R 392±913 56±27 * 292±291d 66±36c
λz(h−1) S 0.23±0.05 0.13±0.02 ** 0.04±0.03b 0.04±0.03c
R 0.29±0.19 0.14±0.03 * 0.05±0.03d 0.05±0.02c
Tmax (h) S 1.0±0.4 1.0±0.6 8±3 10±3
R 1.0±0.3 1.1±0.6 5±4a 9±3 *
Cmax S 30±23 81±17 ** 10±5 35±9 *
(ng/mL) R 20±20 73±18 ** 8±4a 30±9 *
S/R AUC S/R 1.64±0.25 1.17±0.17 ** 1.65±0.37a 1.15±0.11 **
Ratio

Values are reported as geometric mean ± standard deviation.

*

P<0.05;

**

P<0.001;

a

N=9 evaluable;

b

N=6 evaluable;

c

N=5 evaluable;

d

N=7 evaluable